Invention Application
US20160122758A1 AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-W
审中-公开
用于限制BCL-XL和/或BCL-W的活性和/或量的试剂
- Patent Title: AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-W
- Patent Title (中): 用于限制BCL-XL和/或BCL-W的活性和/或量的试剂
-
Application No.: US14784312Application Date: 2014-04-13
-
Publication No.: US20160122758A1Publication Date: 2016-05-05
- Inventor: Valery KRIZHANOVSKY , Noam PILPEL , Reut YOSEF
- Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
- International Application: PCT/IL2014/050358 WO 20140413
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K9/00 ; A61K31/635 ; A61K45/06 ; A61K38/17
Abstract:
A method of treating an inflammatory or fibrotic disease in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which down-regulates an activity and/or an amount of Bcl-xL and/or Bcl-w and/or p21, with the proviso that the inflammatory disease is not cancer.
Information query
IPC分类:
